Literature DB >> 6387489

Antithyroid drugs.

D S Cooper.   

Abstract

Over the past four decades, a great deal has been learned about the pharmacology and mechanisms of action of antithyroid drugs. Their ability to inhibit hormone biosynthesis involves complex interactions with thyroid peroxidase and thyroglobulin, many of which are still poorly understood. Their spectrum of activity is much wider than previously thought, and a number of clinically important extrathyroidal actions have been identified. Despite a greater appreciation for the intricacies of antithyroid-drug pharmacology, controversies still surround the use of these agents in the treatment of thyrotoxicosis. These controversies are apt to continue until the pathophysiology of Graves' disease is fully elucidated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6387489     DOI: 10.1056/NEJM198411223112106

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  55 in total

Review 1.  Diagnosis and management of Graves' disease.

Authors:  Jody Ginsberg
Journal:  CMAJ       Date:  2003-03-04       Impact factor: 8.262

2.  Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil.

Authors:  C Y Hayashida; A J Duarte; A E Sato; E H Yamashiro-Kanashiro
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

3.  Remission of Graves' disease with hyperthyroidism by a combination of glucocorticoids and antithyroid drugs.

Authors:  S A Peter
Journal:  J Natl Med Assoc       Date:  1991-03       Impact factor: 1.798

Review 4.  Best practice in primary care pathology: review 4.

Authors:  W S A Smellie; J Forth; S Sundar; E Kalu; C A M McNulty; E Sherriff; I D Watson; C Croucher; T M Reynolds; P J Carey
Journal:  J Clin Pathol       Date:  2006-05-19       Impact factor: 3.411

5.  Antineutrophil cytoplasmic antibody-positive vasculitis associated with propylthiouracil therapy.

Authors:  S Dinmezel; C Ogus; T Ozdemir
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

6.  Asymptomatic hematuria.

Authors:  B Gauthier; H Trachtman
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

Review 7.  Autoimmune thyroid disease and pregnancy.

Authors:  N Amino; H Tada; Y Hidaka
Journal:  J Endocrinol Invest       Date:  1996-01       Impact factor: 4.256

Review 8.  Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.

Authors:  R I Henkin
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

9.  Simple modifications to methimazole that enhance its inhibitory effect on tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression by human endothelial cells.

Authors:  Anuja Alapati; Sudhir P Deosarkar; Olivia L Lanier; Chunyan Qi; Grady E Carlson; Monica M Burdick; Frank L Schwartz; Kelly D McCall; Stephen C Bergmeier; Douglas J Goetz
Journal:  Eur J Pharmacol       Date:  2015-01-29       Impact factor: 4.432

10.  Neuromedin U-like immunoreactivity in the thyroid gland of the rat.

Authors:  J Domin; A M Al-Madani; M Desperbasques; A E Bishop; J M Polak; S R Bloom
Journal:  Cell Tissue Res       Date:  1990-04       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.